- Patient Information:
Details with Side Effects
EVOCLIN Foam is indicated for topical application in the treatment of acne vulgaris in patients 12 years and older.
DOSAGE AND ADMINISTRATION
EVOCLIN Foam is for topical use only, and not for oral, ophthalmic, or intravaginal use.
Apply EVOCLIN Foam once daily to affected areas after the skin is washed with mild soap and allowed to fully dry. Use enough to cover the entire affected area.
If there has been no improvement after 6 to 8 weeks or if the condition becomes worse, treatment should be discontinued.
The contents of EVOCLIN Foam are flammable; avoid fire, flame and/or smoking during and immediately following application.
Dosage Forms And Strengths
White to off-white thermolabile foam. Each gram of EVOCLIN Foam contains, as dispensed, 12 mg (1.2%) of clindamycin phosphate, equivalent to 10 mg (1%) of clindamycin.
EVOCLIN Foam containing clindamycin phosphate equivalent to 10 mg clindamycin per gram, is white to off-white in color and thermolabile. It is available in the following sizes:
100 gram aerosol can - NDC 0145-0061-00
50 gram aerosol can - NDC 0145-0061-50
Storage and Handling
Store at controlled room temperature between 68°F to 77°F (20°C to 25°C).
Flammable. Avoid fire, flame or smoking during and immediately following application.
Contents under pressure. Do not puncture or incinerate. Do not expose to heat or store at temperature above 120°F (49°C).
Keep out of reach of children.
Manufactured for: Stiefel Laboratories, Inc. Research Triangle Park, NC 27709. Revised: 1/2012
Last reviewed on RxList: 2/9/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Evoclin Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.